Company Overview - Harvard Bioscience, Inc. is a leading developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production, and preclinical testing for pharmaceutical and therapy development [5] - The company's customer base includes renowned academic institutions, government laboratories, and leading pharmaceutical, biotechnology, and contract research organizations [5] - Harvard Bioscience operates in North America, Europe, and China, utilizing both direct and distribution channels to reach customers globally [5] Investor Engagement - The company announced that Jim Green, Chairman and CEO, and Jennifer Cote, CFO, will present to investors at the 14th Annual East Coast IDEAS Conference on June 12, 2024 [4] - The presentation is scheduled for 2:45-3:20 PM ET and will be webcast live, with a replay available shortly after [2][4] - One-on-one investor meetings will also be hosted throughout the day, with scheduling available through the conference team [2]
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024